About Lovego

Lovego is young and the brand is built on July 2013. Our first POC is Lovego G1 which give clients another choice for portable oxygen therapy with continuous flow. To meet more clients needs on the battery life, the larger flow, the lighter weight. We designed the G1 plus, G2, and G2 plus POC. 

Now our POC can nearly meet all the needs of friends who needs home oxygen therapy from 1LPM-6LPM. However We are not perfect and must keep moving on. With the technology development of related part Support services. We believe the POC will replace the home kind completely in future. Maybe it will be small as a mobile phone and whole day battery life. 

To improve the day life of our clients, we are also Committed to Food therapy, sport therapy, sharing daily life tips in the way of Weekly Report and Facebook Group COPD Service. Here you are not alone, we are together to make life easier, happier and own our independent lifestyle. 

Lovego,  Let’s Go Along With Love!

News             Updated: Nov.1st 2018


MEDICA 2018 will be held from 12-15th, November, Düsseldorf , Germany. It is the world's leading international trade fair for the medical sector. MEDICA regularly features around 4,600 exhibitors from around the world displaying the OEM products and services over an exhibit area consisting of 19 halls and spanning nearly 1.3 million net square feet of exhibit space.

This year, we, Oxytek Medical Technology Co.,Ltd, will join the exhibitors and bring the Lovego oxygen concentrators to the exhibition.

Our Booth No. is 16E80-5

At that time, the Lovego newest portable oxygen concentrator LG103 will be unveiled at MEDICA. And there are other machines like the first generation POC LG101, the second generation POC LG102P, and the home oxygen concentrators LG301,LG1002 ect

We, Oxytek Medical Technology Co.,Ltd are specialized in oxygen concentrator,we're the world-wide specialist in oxygen systems for medical, homecare, healthcare device company. We sincerely and warmly welcome you to visit, observe, guide and consult personally.